Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 748

1.

Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?

Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Kodaka F, Okumura M, Otsuka T, Suhara T.

J Neurosci. 2009 Oct 28;29(43):13730-4. doi: 10.1523/JNEUROSCI.4172-09.2009.

PMID:
19864585
[PubMed - indexed for MEDLINE]
Free Article
2.

Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.

Ito H, Takano H, Arakawa R, Takahashi H, Kodaka F, Takahata K, Nogami T, Suzuki M, Suhara T.

PLoS One. 2012;7(9):e46488. doi: 10.1371/journal.pone.0046488. Epub 2012 Sep 28.

PMID:
23029533
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.

Remington G, Mamo D, Labelle A, Reiss J, Shammi C, Mannaert E, Mann S, Kapur S.

Am J Psychiatry. 2006 Mar;163(3):396-401.

PMID:
16513859
[PubMed - indexed for MEDLINE]
4.

No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study.

Ito H, Arakawa R, Takahashi H, Takano H, Okumura M, Otsuka T, Ikoma Y, Shidahara M, Suhara T.

Int J Neuropsychopharmacol. 2009 Jun;12(5):667-75. doi: 10.1017/S1461145708009577. Epub 2008 Oct 21.

PMID:
18937879
[PubMed - indexed for MEDLINE]
5.

Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.

Ito H, Takahashi H, Arakawa R, Takano H, Suhara T.

Neuroimage. 2008 Jan 15;39(2):555-65. Epub 2007 Sep 19.

PMID:
17962043
[PubMed - indexed for MEDLINE]
6.

The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.

Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S.

Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi: 10.1001/archgenpsychiatry.2009.43.

PMID:
19487625
[PubMed - indexed for MEDLINE]
7.

Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.

Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L.

Am J Psychiatry. 1999 Jun;156(6):869-75.

PMID:
10360125
[PubMed - indexed for MEDLINE]
8.

Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine.

Kodaka F, Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Okumura M, Otsuka T, Nakayama K, Halldin C, Farde L, Suhara T.

Int J Neuropsychopharmacol. 2011 Feb;14(1):83-9. doi: 10.1017/S1461145710001148. Epub 2010 Sep 22.

PMID:
20860881
[PubMed - indexed for MEDLINE]
9.

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.

Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B.

Psychopharmacology (Berl). 1993;110(3):265-72.

PMID:
7530376
[PubMed - indexed for MEDLINE]
10.

Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.

Hall H, Halldin C, Nyberg S, Farde L, Sedvall G.

Eur Neuropsychopharmacol. 1995 Mar;5(1):19-25.

PMID:
7542051
[PubMed - indexed for MEDLINE]
11.

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

Kapur S, Zipursky RB, Remington G.

Am J Psychiatry. 1999 Feb;156(2):286-93.

PMID:
9989565
[PubMed - indexed for MEDLINE]
12.

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.

Uchida H, Mamo DC, Kapur S, Labelle A, Shammi C, Mannaert EJ, Mann SW, Remington G.

J Clin Psychiatry. 2008 Aug;69(8):1281-6.

PMID:
18642974
[PubMed - indexed for MEDLINE]
13.

Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.

Ikoma Y, Ito H, Arakawa R, Okumura M, Seki C, Shidahara M, Takahashi H, Kimura Y, Kanno I, Suhara T.

Neuroimage. 2008 Oct 1;42(4):1285-94. doi: 10.1016/j.neuroimage.2008.05.056. Epub 2008 Jun 10.

PMID:
18585466
[PubMed - indexed for MEDLINE]
14.

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.

Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.

Am J Psychiatry. 2004 Sep;161(9):1620-5.

PMID:
15337652
[PubMed - indexed for MEDLINE]
15.

Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.

Arakawa R, Ito H, Takano A, Takahashi H, Morimoto T, Sassa T, Ohta K, Kato M, Okubo Y, Suhara T.

Psychopharmacology (Berl). 2008 Apr;197(2):229-35. Epub 2007 Dec 6.

PMID:
18058087
[PubMed - indexed for MEDLINE]
16.

Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: implication of dopaminergic tone.

Ito H, Kodaka F, Takahashi H, Takano H, Arakawa R, Shimada H, Suhara T.

J Neurosci. 2011 May 25;31(21):7886-90. doi: 10.1523/JNEUROSCI.6024-10.2011.

PMID:
21613502
[PubMed - indexed for MEDLINE]
Free Article
17.

The relationship between subjective well-being and dopamine D2 receptors in patients treated with a dopamine partial agonist and full antagonist antipsychotics.

Mizrahi R, Mamo D, Rusjan P, Graff A, Houle S, Kapur S.

Int J Neuropsychopharmacol. 2009 Jun;12(5):715-21. doi: 10.1017/S1461145709000327. Epub 2009 Apr 15.

PMID:
19366489
[PubMed - indexed for MEDLINE]
18.

Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Muly EC, Votaw JR, Ritchie J, Howell LL.

J Pharmacol Exp Ther. 2012 Apr;341(1):81-9. doi: 10.1124/jpet.111.189076. Epub 2012 Jan 3.

PMID:
22214649
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.

Gefvert O, Eriksson B, Persson P, Helldin L, Björner A, Mannaert E, Remmerie B, Eerdekens M, Nyberg S.

Int J Neuropsychopharmacol. 2005 Mar;8(1):27-36.

PMID:
15710053
[PubMed - indexed for MEDLINE]
20.

Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.

Arakawa R, Okumura M, Ito H, Takano A, Takahashi H, Takano H, Maeda J, Okubo Y, Suhara T.

J Clin Psychiatry. 2010 Sep;71(9):1131-7. doi: 10.4088/JCP.08m04307yel. Epub 2010 Feb 23.

PMID:
20361897
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk